Your browser doesn't support javascript.
Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network.
Garza-Ramos, Ulises; Silva-Sánchez, Jesús; López-Jácome, Luis Esaú; Hernández-Durán, Melissa; Colín-Castro, Claudia Adriana; Sánchez-Pérez, Alejandro; Rodríguez-Santiago, Jonathan; Morfín-Otero, Rayo; Rodriguez-Noriega, Eduardo; Velázquez-Acosta, María-Del-Consuelo; Vázquez-Larios, María Del Rosario; Feliciano-Guzmán, José Manuel; Rojas-Larios, Fabián; Ponce-De-Leon, Alfredo; Lozano-Garcia, Margarita; Choy-Chang, Elena Victoria; López-Gutiérrez, Eduardo; Molina-Jaimes, Aarón; Gil-Veloz, Mariana; Corte-Rojas, Reyna Edith; López-Ovilla, Ismelda; Ramirez-Mis, Jose Luis; Rodríguez-Balderas, Dora Elia; Molina-Chavarria, Alejandro; Padilla-Ibarra, Cecilia; Quevedo-Ramos, Maria Angelina; Mireles-Dávalos, Christian Daniel; Rodríguez-Medina, Nadia; Rubio-Mendoza, Daira; Córdova-Fletes, Carlos; Cruz-López, Flora; Becerra-Montejano, Dilva Angelina; Mercado-Longoria, Roberto; Martínez-Villarreal, Rebeca Thelma; Barlandas-Rendón, Nicolás Rogelio Eric; Mena-Ramírez, Juan Pablo; Couoh-May, Carlos Antonio; Alcaraz-Espejel, Margarita; Adame-Alvarez, César; Hernández-Vicente, Lourdes; Garza-González, Elvira.
  • Garza-Ramos U; Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.
  • Silva-Sánchez J; Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.
  • López-Jácome LE; Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México, Mexico.
  • Hernández-Durán M; Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México, Mexico.
  • Colín-Castro CA; Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México, Mexico.
  • Sánchez-Pérez A; Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.
  • Rodríguez-Santiago J; Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.
  • Morfín-Otero R; Hospital Civil de Guadalajara Fray Antonio Alcalde, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.
  • Rodriguez-Noriega E; Hospital Civil de Guadalajara Fray Antonio Alcalde, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.
  • Velázquez-Acosta MD; Instituto Nacional de Cancerología, Ciudad de México, Mexico.
  • Vázquez-Larios MDR; Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de Mexico, Mexico.
  • Feliciano-Guzmán JM; Hospital de Especialidades Pediátricas, Tuxtla Gutiérrez, Chiapas, Mexico.
  • Rojas-Larios F; Laboratorio de Ecología y Microbiología, Facultad de Medicina, Universidad de Colima, Colima, Mexico.
  • Ponce-De-Leon A; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de Mexico, Mexico.
  • Lozano-Garcia M; Hospital General Dr. Manuel Gea González, Ciudad de México, Mexico.
  • Choy-Chang EV; Hospital General de Zona No.1 Nueva Frontera, Tapachula, Chiapas, Mexico.
  • López-Gutiérrez E; Hospital Regional de Alta Especialidad de Oaxaca, San Bartolo Coyotepec, Oaxaca, Mexico.
  • Molina-Jaimes A; Hospital Regional de Alta Especialidad Bicentenario de la Independencia, Tultitlán de Mariano Escobedo, Estado de México, Mexico.
  • Gil-Veloz M; Hospital Regional de Alta Especialidad del Bajío, Leon, Guanajuato, Mexico.
  • Corte-Rojas RE; Hospital para el Niño Poblano, San Andrés Cholula, Puebla, Mexico.
  • López-Ovilla I; Hospital Dr. Gilberto Gomez Maza, Tuxtla Gutiérrez, Chiapas, Mexico.
  • Ramirez-Mis JL; Hospital Galenia, Cancun, Quintana Roo, Mexico.
  • Rodríguez-Balderas DE; Hospital del Niño Dr. Federico Gómez Santos, Saltillo, Coahuila, Mexico.
  • Molina-Chavarria A; Centro médico Dr. Ignacio Chávez, Hermosillo, Sonora, Mexico.
  • Padilla-Ibarra C; Hospital General del Estado Dr. Ernesto Ramos Bours, Hermosillo, Sonora, Mexico.
  • Quevedo-Ramos MA; Hospital General León, Leon, Guanajuato, Mexico.
  • Mireles-Dávalos CD; Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Ciudad de México, Mexico.
  • Rodríguez-Medina N; Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.
  • Rubio-Mendoza D; Facultad de Medicina, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
  • Córdova-Fletes C; Facultad de Medicina, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
  • Cruz-López F; Facultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
  • Becerra-Montejano DA; Hospital General Dr. Miguel Silva, Morelia, Michoacán, Mexico.
  • Mercado-Longoria R; Facultad de Medicina, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
  • Martínez-Villarreal RT; Centro Universitario de Salud, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
  • Barlandas-Rendón NRE; Laboratorio BIOCLIN SA DE CV, Chilpancingo, Guerrero, Mexico.
  • Mena-Ramírez JP; Hospital General de Zona N. 21 IMSS, Centro Universitario de los Altos CUALTOS, Tepatitlán de Morelos, Jalisco, Mexico.
  • Couoh-May CA; Hospital General Dr. Agustín O'Horan, Mérida, Yucatán, Mexico.
  • Alcaraz-Espejel M; Sanatorio la luz, Morelia, Michoacan, Mexico.
  • Adame-Alvarez C; Hospital Centenario Miguel Hidalgo, Aguascalientes, Mexico.
  • Hernández-Vicente L; Hospital General Dr. Raymundo Abarca Alarcón, Chilpancingo de los Bravo, Guerrero, Mexico.
  • Garza-González E; Facultad de Medicina, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
Microb Drug Resist ; 29(6): 239-248, 2023 Jun.
Article in English | MEDLINE | ID: covidwho-2188111
ABSTRACT
In this study, we report the carbapenemase-encoding genes and colistin resistance in Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa in the second year of the COVID-19 pandemic. Clinical isolates included carbapenem-resistant K. pneumoniae, carbapenem-resistant E. coli, carbapenem-resistant A. baumannii, and carbapenem-resistant P. aeruginosa. Carbapenemase-encoding genes were detected by PCR. Carbapenem-resistant K. pneumoniae and carbapenem-resistant E. coli isolates were analyzed using the Rapid Polymyxin NP assay. mcr genes were screened by PCR. Pulsed-field gel electrophoresis and whole-genome sequencing were performed on representative isolates. A total of 80 carbapenem-resistant E. coli, 103 carbapenem-resistant K. pneumoniae, 284 carbapenem-resistant A. baumannii, and 129 carbapenem-resistant P. aeruginosa isolates were recovered. All carbapenem-resistant E. coli and carbapenem-resistant K. pneumoniae isolates were included for further analysis. A selection of carbapenem-resistant A. baumannii and carbapenem-resistant P. aeruginosa strains was further analyzed (86 carbapenem-resistant A. baumannii and 82 carbapenem-resistant P. aeruginosa). Among carbapenem-resistant K. pneumoniae and carbapenem-resistant E. coli isolates, the most frequent gene was blaNDM (86/103 [83.5%] and 72/80 [90%], respectively). For carbapenem-resistant A. baumannii, the most frequently detected gene was blaOXA-40 (52/86, 60.5%), and for carbapenem-resistant P. aeruginosa, was blaVIM (19/82, 23.2%). For carbapenem-resistant A. baumannii, five indistinguishable pulsotypes were detected. Circulation of K. pneumoniae New Delhi metallo-ß-lactamase (NDM) and E. coli NDM was detected in Mexico. High virulence sequence types (STs), such as K. pneumoniae ST307, E. coli ST167, P. aeruginosa ST111, and A. baumannii ST2, were detected. Among K. pneumoniae isolates, 18/101 (17.8%) were positive for the Polymyxin NP test (two, 11.0% positive for the mcr-1 gene, and one, 5.6% with disruption of the mgrB gene). All E. coli isolates were negative for the Polymyxin NP test. In conclusion, K. pneumoniae NDM and E. coli NDM were detected in Mexico, with the circulation of highly virulent STs. These results are relevant in clinical practice to guide antibiotic therapies considering the molecular mechanisms of resistance to carbapenems.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Colistin / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Country/Region as subject: Mexico Language: English Journal: Microb Drug Resist Journal subject: Microbiology / Drug Therapy Year: 2023 Document Type: Article Affiliation country: Mdr.2022.0226

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Colistin / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Country/Region as subject: Mexico Language: English Journal: Microb Drug Resist Journal subject: Microbiology / Drug Therapy Year: 2023 Document Type: Article Affiliation country: Mdr.2022.0226